A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.
D000744:Anemia, Hemolytic, Autoimmune / Q000628:therapy; D001667:Binding, Competitive; D001792:Blood Platelets / Q000276:immunology*; D003176:Complement C3 / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006242:Haptoglobins / Q000032:analysis; D006461:Hemolysis; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D007263:Infusions, Parenteral; D012157:Mononuclear Phagocyte System / Q000276:immunology; D011696:Purpura, Thrombocytopenic / Q000276:immunology / Q000628:therapy
D003176:Complement C3; D006242:Haptoglobins; D007074:Immunoglobulin G